Victrex (LON:VCT - Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from GBX 940 ($12.68) to GBX 818 ($11.03) in a report released on Wednesday, Marketbeat.com reports. The brokerage presently has a "neutral" rating on the stock. JPMorgan Chase & Co.'s target price points to a potential upside of 12.92% from the company's previous close.
Victrex Price Performance
VCT traded down GBX 3.60 ($0.05) during trading on Wednesday, hitting GBX 724.40 ($9.77). 171,582 shares of the stock traded hands, compared to its average volume of 414,972. Victrex has a twelve month low of GBX 667.62 ($9.01) and a twelve month high of GBX 1,160 ($15.65). The company has a market cap of £631.91 million, a price-to-earnings ratio of 20.58, a PEG ratio of 1.92 and a beta of 0.69. The company has a debt-to-equity ratio of 10.93, a current ratio of 4.39 and a quick ratio of 1.99. The business has a 50 day moving average price of GBX 793.01 and a 200 day moving average price of GBX 887.05.
Victrex (LON:VCT - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported GBX 22.60 ($0.30) EPS for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. Equities research analysts forecast that Victrex will post 73.1078905 earnings per share for the current fiscal year.
Insider Buying and Selling at Victrex
In other Victrex news, insider David Thomas acquired 1,158 shares of Victrex stock in a transaction that occurred on Tuesday, May 13th. The shares were bought at an average price of GBX 846 ($11.41) per share, with a total value of £9,796.68 ($13,215.54). Also, insider Dame Vivienne Cox purchased 2,747 shares of the business's stock in a transaction on Tuesday, July 8th. The shares were purchased at an average cost of GBX 721 ($9.73) per share, for a total transaction of £19,805.87 ($26,717.75). Insiders own 1.64% of the company's stock.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
